AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Amlodipine Besylate, Valsartan And Hydrochlorothiazide, and when can generic versions of Amlodipine Besylate, Valsartan And Hydrochlorothiazide launch?

Amlodipine Besylate, Valsartan And Hydrochlorothiazide is a drug marketed by Aurobindo Pharma, Lupin Ltd, Strides Pharma, Teva Pharms, and Torrent. and is included in five NDAs.

The generic ingredient in AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE is amlodipine besylate; hydrochlorothiazide; valsartan. There are fifty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; valsartan profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE?
What are the global sales for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE?
What is Average Wholesale Price for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE?

Summary for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

US Patents:	0
Applicants:	5
NDAs:	5
Finished Product Suppliers / Packagers:	3
DailyMed Link:	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE at DailyMed

Drug patent expirations by year for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Pharmacology for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Drug Class	Angiotensin 2 Receptor Blocker Calcium Channel Blocker Dihydropyridine Calcium Channel Blocker Thiazide Diuretic
Mechanism of Action	Angiotensin 2 Receptor Antagonists Calcium Channel Antagonists Cytochrome P450 3A Inhibitors
Physiological Effect	Increased Diuresis

US Patents and Regulatory Information for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	206180-001	Dec 19, 2017	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	200435-005	Sep 25, 2012		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Torrent	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	201593-004	Jun 3, 2015		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lupin Ltd	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	200797-002	Jun 3, 2015	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	206180-004	Dec 19, 2017	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Strides Pharma	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	201087-002	Jun 1, 2015	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	200435-004	Sep 25, 2012		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

AI Research Assistant

Questions you can ask:

Summary for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Pharmacology for AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE

Make Better Decisions: Try a trial or see plans & pricing